Neuphoria Therapeutics (NEUP) Non-Current Assets (2021 - 2026)
Neuphoria Therapeutics' Non-Current Assets came in at $7.64 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 43.6% from $13.55 million a year earlier and down 41.9% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Non-Current Assets (2021 - 2026) Analysis & Trends
Going back to fiscal Q4 2021, Neuphoria Therapeutics' Non-Current Assets data covers 12 quarters.
- Non-Current Assets has declined in each of the last five fiscal years, with a five-year compound annual growth rate of -15.7% (FY2021 to FY2026).
- Going back by fiscal year, Non-Current Assets was $13.55 million in FY2025 (-6.3%), $14.46 million in FY2024 (-5.6%), $15.31 million in FY2023 (-9.0%) and $16.83 million in FY2022 (-6.3%).
- The fiscal Q4 2026 figure represents the lowest quarterly Non-Current Assets in data going back to fiscal Q4 2021.
- Year-over-year, Non-Current Assets has declined for five consecutive quarters, with an average decline of 13.0% over the last five quarters.
- Across the past five years, year-over-year decline in Non-Current Assets ran from 3.5% in fiscal Q3 2026 to 43.6% in fiscal Q4 2026.
- Business Quant data shows NEUP's Non-Current Assets at $13.15 million (Q3 2026), $13.21 million (Q2 2026) and $13.39 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Neuphoria Therapeutics | 422.60 Mn | 347.41 Mn | - | 7.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.64 Mn |
| Mar 31, 2026 | 13.15 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | 13.39 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Mar 31, 2025 | 13.62 Mn |
| Dec 31, 2024 | 13.77 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 14.46 Mn |
| Jun 30, 2023 | 15.16 Mn |
| Jun 30, 2022 | 16.17 Mn |
| Jun 30, 2021 | 17.53 Mn |
API Access
Neuphoria Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();